IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Karyopharm Therapeutics

Q2 2025 vs Q3 2025

Comparing institutional holders between quarters

Quarters

Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile
Affinity Asset Advisors, LLC
UNCHANGED
Shares15,250,000 from 15,250,000
Change0 (0%)
Value$12.5M (+$835.7K)
Filed 2025-11-13
Opaleye Management Inc.
UNCHANGED
Shares6,000,000 from 6,000,000
Change0 (0%)
Value$4.6M (+$74.8K)
Filed 2025-11-14
Exome Asset Management LLC
UNCHANGED
Shares2,000,000 from 2,000,000
Change0 (0%)
Value$1.6M (+$109.6K)
Filed 2025-11-14
BLB&B Advisors, LLC
UNCHANGED
Shares75,000 from 75,000
Change0 (0%)
Value$60.5K (+$3.6K)
Filed 2025-10-31
JPMorgan Chase & Co
UNCHANGED
Shares38,000 from 38,000
Change0 (0%)
Value$37.3K (+$7.5K)
Filed 2025-11-26
Proequities, Inc.
N/A
Shares— from 0
Change0
Value—
Status
Affinity Asset Advisors, LLC
UNCHANGED15,250,00015,250,00000%$11.6M$12.5M+$835.7K2025-11-13
Opaleye Management Inc.
UNCHANGED6,000,0006,000,00000%$4.6M$4.6M+$74.8K2025-11-14
Exome Asset Management LLC
UNCHANGED2,000,0002,000,00000%$1.5M$1.6M+$109.6K2025-11-14
BLB&B Advisors, LLC
UNCHANGED75,00075,00000%$56.9K$60.5K+$3.6K2025-10-31
JPMorgan Chase & Co
UNCHANGED38,00038,00000%$29.8K$37.3K+$7.5K2025-11-26
Proequities, Inc.
N/A—00—$0———
Showing 6 of 6 institutions